Sign up for the Freshfields TQ digest
MedTech M&A, Strategic MedTech Collaborations
The combination of rapid technological innovation and disruption of traditional models of care has accelerated the integration of MedTech offerings in healthcare.
Our global MedTech practice is a core component of the firm’s life sciences group. Our team combines the world’s leading M&A, capital markets and antitrust attorneys with deep life sciences, technology and MedTech expertise. Through a cross-disciplinary approach, we advise our MedTech clients, including life sciences businesses, technology firms, healthcare companies and providers, and investors, on their most critical and complex M&A, joint venture, licence, collaboration, capital markets and other strategic transactions. Our MedTech expertise spans medical devices (including SaMD) as well as a range of digital health and health IT products, services and platforms.
Our MedTech insights
Our MedTech experience
General Atlantic on its investment in the Series B funding round of Reliance Health, Inc., an emerging-markets-focused digital healthcare provider primarily based in Nigeria.
EQT on its acquisition of Siemens Audiology Solutions, a hearing aid manufacturer.
General Atlantic on its acquisition of a stake in Doctolib, a France-based operator of an online and mobile booking platform connecting doctors and patients.
Essity on a collaboration with German start-up Colorimetrix regarding the development and customization of a fertility app and the accompanying test strips.
Ottobock on its collaboration with the German/US start-up company Motesque on the development of a sensor system that can measure malposition of the patient as a basis for further therapy supported by a cloud-based SaaS offering.
Genomic Health on data protection, regulatory and reimbursement eligibility aspects regarding the market entry of the gene expression test ‘Oncotype DX’ in Germany and throughout Europe.
A UK-based hospital on all aspects of its use of patient data – from gathering consent (informed consent and consent for data processing) to anonymisation and partnering with commercial entities.
Temedica on collaborations with pharmaceutical companies for the development of patient companion apps to be used for clinical studies and setting up the contractual framework for Temedica’s health insight product offerings.
Grünenthal pharma on regulatory questions in relation to health applications and telemedicine products.
Fortune 10 company on the development of wearable and other mobility devices.
An industry leader on comprehensive genomic profiling, and a leading provider of electronic medical record (EMR) technology and real-world evidence data solutions, in a multimillion-dollar collaboration with OneOncology to advance personalized cancer care.
A Fortune 100 company on its collaboration agreement with Premier, a leading healthcare improvement company, to enable projects involving healthcare data analytics and the development and commercialization of patient and provider healthcare solutions.
A global pharmaceutical company on its development deal to incorporate a dosing system regulated as a medical device into the company’s app.
Our MedTech team
Vinita Kailasanath Partner
Dr. Philipp Dohnke Partner
Giles Pratt Partner
Dr. Christoph Werkmeister Partner
Sharon Malhi Partner
Rod Carlton Partner
Menachem Kaplan Partner
Dr. Michael Ramb Partner
Timothy Harkness Partner